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Rare diseases affect fewer than one person in 
2000 in Europe. There are >6000 that have been 
identified, with the majority (80%) being genetic in 
origin [1]. Due to the small number of people living 
with these conditions, they are often neglected; 
diagnosis is difficult and treatment options limited. 
European reference networks (ERNs) are a new 
European Union (EU) initiative that aims to ensure 
that people living with rare conditions can benefit 
from the best treatment and advice wherever they 
live in the EU (https://ern-lung.eu/).
ERN-LUNG is the respiratory focused ERN, the 
vision of which is to be a European knowledge 
hub for rare and complex lung diseases, and to 
decrease morbidity and mortality in people of all 
ages. This ERN covers nine disease areas, including 
interstitial lung diseases, cystic fibrosis, pulmonary 
hypertension, primary ciliary dyskinesia, non-cystic 
fibrosis bronchiectasis, α1-antitrypsin deficiency, 
mesothelioma, chronic lung allograft dysfunction 
and other rare lung diseases.
As well as these core disease areas, ERN-LUNG 
has nine functional committees: research and 
clinical trials, ethical issues, registries and biobanks, 
patient-recorded outcomes, quality management, 
guidelines and best practice of care, communication 
and outreach, cross-border care, and training and 
education. The aim of the education committee 
is to ensure that professionals and patients can 
access up-to-date and relevant educational 
materials to help diagnose, treat and manage rare 
lung conditions.
The education committee felt that a good 
starting point for the work of the group was to 
carry out a survey among ERN members (healthcare 
professionals working in national reference centres) 
and patients (from the European Lung Foundation 
(ELF) patient organisation network) to find out the 
current situation in Europe.
The survey
A total of 52 healthcare professionals (out of 60 
invited) and 57 patient representatives responded to 
the survey, which was composed of seven questions 
for healthcare professionals and five for patients, 
and was posted on SurveyMonkey in English for 
3 months.
The view of healthcare 
professionals
>75% of healthcare professionals are aware of 
educational resources in the field of rare lung 
diseases and 95% believe that those resources 
are relevant for delivering the educational mission 
of ERN-LUNG. A comprehensive list has been put 
together based on the resources suggested by survey 
respondents (available at https://ern-lung.eu/).
There was a consensus that education is 
mandatory but none on the form that educational 
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resources should take, and a variety were supported 
including postgraduate courses, online courses and 
webinars, case-based sessions, and expert forums.
The survey respondents were asked to give a 
preference on who should develop educational 
resources in the field of rare lung diseases, and the 
majority (>75%) suggested that materials should be 
developed in partnership with organisations such 
as the European Respiratory Society (ERS), and 
integrated into existing meetings and events run 
by such organisations.
The view of patients
From a patient’s perspective, 88.5% of respondents 
thought there was a need for patient education at 
a European level. However, only 34.8% were aware 
of such activities. Several resources were indicated, 
which are also available at https://ern-lung.eu/. 
Patients reported a number of barriers that prevent 
them from accessing education; these include 
language, cost of travel, and bad health limiting how 
and when they can travel. Due to these limitations, 
67.5% and 82.5% of respondents indicated that 
online meetings and online resources, respectively, 
would be the preferred route of delivering 
educational resources, although 60% still suggested 
that face-to-face meetings would be welcomed. 
Finally, an overwhelming majority (95%) of patients 
who responded thought that patients had a role to 
play in the education of professionals.
Conclusions
It is vital that education in the field of rare lung rare 
disease is made a priority within and outside of the 
ERN-LUNG and for healthcare givers as well as for 
patients. The conclusions taken from the survey 
are as follows.
●● A dynamic overview of resources should be made 
available on the ERN-LUNG website that can be 
regularly updated.
●● Education should be performed in conjunction 
with medical societies (e.g. ERS) and patient-
focused organisations (e.g. ELF).
●● There should be a conscious effort to make 
patient educational materials more accessible by 
translation and improving online functionality.
●● There is an urgent need for funding to structurally 
improve education and access to education for 
all healthcare professionals and patients in 
Europe in the field of rare lung disease.
These conclusions will be taken forward by the 
education committee of ERN-LUNG and we invite 
all those working in the field to get involved.
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